Clearbridge Investments LLC lowered its position in Trupanion, Inc. (NASDAQ:TRUP – Free Report) by 23.2% in the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 663,339 shares of the financial services provider’s stock after selling 199,866 shares during the quarter. Clearbridge Investments LLC’s holdings in Trupanion were worth $18,315,000 at the end of the most recent quarter.
Other large investors have also added to or reduced their stakes in the company. Vanguard Group Inc. grew its position in Trupanion by 0.9% in the 1st quarter. Vanguard Group Inc. now owns 3,673,791 shares of the financial services provider’s stock valued at $101,433,000 after purchasing an additional 32,485 shares during the period. Wellington Management Group LLP grew its holdings in shares of Trupanion by 34.6% during the fourth quarter. Wellington Management Group LLP now owns 2,453,685 shares of the financial services provider’s stock valued at $74,862,000 after buying an additional 630,155 shares during the last quarter. Sivia Capital Partners LLC acquired a new stake in shares of Trupanion in the 4th quarter worth about $31,398,000. 8 Knots Management LLC bought a new position in Trupanion in the 4th quarter valued at about $21,165,000. Finally, Charles Schwab Investment Management Inc. boosted its stake in Trupanion by 2.4% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 300,029 shares of the financial services provider’s stock valued at $9,154,000 after purchasing an additional 7,088 shares during the last quarter.
Trupanion Stock Performance
TRUP traded down $1.39 during trading on Wednesday, hitting $32.53. 591,354 shares of the company traded hands, compared to its average volume of 697,634. Trupanion, Inc. has a one year low of $19.14 and a one year high of $36.66. The stock’s fifty day moving average is $29.43 and its 200 day moving average is $27.58. The company has a quick ratio of 1.62, a current ratio of 1.62 and a debt-to-equity ratio of 0.42. The firm has a market cap of $1.37 billion, a P/E ratio of -49.72 and a beta of 1.77.
Insider Buying and Selling
In other Trupanion news, EVP Steve Weinrauch sold 1,000 shares of the stock in a transaction on Thursday, May 30th. The stock was sold at an average price of $29.35, for a total transaction of $29,350.00. Following the completion of the transaction, the executive vice president now directly owns 55,896 shares of the company’s stock, valued at $1,640,547.60. The sale was disclosed in a filing with the SEC, which is available through the SEC website. In other Trupanion news, EVP Steve Weinrauch sold 1,000 shares of the company’s stock in a transaction dated Thursday, May 30th. The shares were sold at an average price of $29.35, for a total transaction of $29,350.00. Following the sale, the executive vice president now directly owns 55,896 shares of the company’s stock, valued at $1,640,547.60. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, insider Melissa Joy Hewitt sold 1,200 shares of the stock in a transaction dated Thursday, May 30th. The stock was sold at an average price of $30.04, for a total transaction of $36,048.00. Following the transaction, the insider now owns 6,105 shares of the company’s stock, valued at approximately $183,394.20. The disclosure for this sale can be found here. In the last quarter, insiders have sold 5,325 shares of company stock valued at $144,586. 5.50% of the stock is owned by company insiders.
Analysts Set New Price Targets
A number of research firms have recently weighed in on TRUP. Bank of America upgraded Trupanion from a “neutral” rating to a “buy” rating and raised their target price for the company from $35.00 to $49.00 in a report on Thursday, May 16th. Piper Sandler boosted their price target on shares of Trupanion from $22.00 to $30.00 and gave the stock a “neutral” rating in a report on Friday, June 28th. Canaccord Genuity Group reduced their price objective on shares of Trupanion from $40.00 to $34.00 and set a “buy” rating for the company in a research report on Friday, May 3rd. Finally, William Blair began coverage on Trupanion in a research note on Friday, July 19th. They issued an “outperform” rating on the stock. Three analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $34.40.
Check Out Our Latest Research Report on TRUP
Trupanion Company Profile
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.
See Also
- Five stocks we like better than Trupanion
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Food Processing Company Stock Gets Fried by Recall: Time to Buy
- Trading Stocks: RSI and Why it’s Useful
- Entertainment Stock Offers A Rare and Tempting Entry Opportunity
- How to Invest in Small Cap StocksĀ
- Will China’s Interest Rate Cuts Ignite a Rally for This Stock?
Want to see what other hedge funds are holding TRUP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Trupanion, Inc. (NASDAQ:TRUP – Free Report).
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.